NDRA
ENDRA Life Sciences Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$6.05
+6.51%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-93.8%
Return on equity
-74.5%
Return on assets
-98.7%
Return on invested capital
0.00x
Asset turnover
-$4.8M
Cash from operations
$1.16
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026